HIGHLIGHTS
- who: Charles Dupin and collaborators from the (BoRdeaux Institute of onCology), UMR1312, University of Bordeaux, Bordeaux, France have published the paper: An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid, in the Journal: Cancers 2022, 14,gests 4244 of /2022/
- what: The study shows for the first time that in a preclinical tumor model relevant to human glioblastoma treated as in clinical routine 5-ALA administration although leading to important accumulation of PpIX does not potentiate radiotherapy. The aim of this work was to establish a robust preclinical patient-derived . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.